Overview
Familial hyperalphalipoproteinemia (also known as familial high HDL cholesterol or elevated HDL syndrome) is a genetic condition characterized by persistently elevated levels of high-density lipoprotein cholesterol (HDL-C) in the blood, typically above the 90th percentile for age and sex. HDL cholesterol is commonly referred to as 'good cholesterol' because it plays a role in transporting cholesterol away from the arteries back to the liver for clearance. In most cases, familial hyperalphalipoproteinemia is considered a benign condition and may even be associated with a reduced risk of cardiovascular disease, though this protective effect is not universal and depends on the underlying genetic mechanism. The condition primarily affects lipid metabolism and the cardiovascular system. Most individuals with familial hyperalphalipoproteinemia are asymptomatic and are identified incidentally through routine lipid panel testing. The elevated HDL-C levels run in families and are caused by genetic variants affecting HDL metabolism, including mutations in genes such as CETP (cholesteryl ester transfer protein), LIPC (hepatic lipase), and others involved in HDL remodeling and clearance. Some forms, particularly those due to CETP deficiency, can result in very high HDL-C levels (above 100 mg/dL). Because familial hyperalphalipoproteinemia is generally considered a favorable lipid profile variant rather than a disease requiring treatment, no specific therapy is typically recommended. Management focuses on overall cardiovascular risk assessment and maintaining a healthy lifestyle. It is important to note that extremely elevated HDL-C levels caused by certain genetic variants may not always confer cardiovascular protection and should be evaluated in the context of the individual's complete metabolic and cardiovascular risk profile. Genetic counseling may be offered to affected families to clarify the inheritance pattern and underlying cause.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Familial Hyperalphalipoproteinemia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial Hyperalphalipoproteinemia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial Hyperalphalipoproteinemia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Familial Hyperalphalipoproteinemia.
Community
No community posts yet. Be the first to share your experience with Familial Hyperalphalipoproteinemia.
Start the conversation →Latest news about Familial Hyperalphalipoproteinemia
No recent news articles for Familial Hyperalphalipoproteinemia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial Hyperalphalipoproteinemia
What is Familial Hyperalphalipoproteinemia?
Familial hyperalphalipoproteinemia (also known as familial high HDL cholesterol or elevated HDL syndrome) is a genetic condition characterized by persistently elevated levels of high-density lipoprotein cholesterol (HDL-C) in the blood, typically above the 90th percentile for age and sex. HDL cholesterol is commonly referred to as 'good cholesterol' because it plays a role in transporting cholesterol away from the arteries back to the liver for clearance. In most cases, familial hyperalphalipoproteinemia is considered a benign condition and may even be associated with a reduced risk of cardiov
How is Familial Hyperalphalipoproteinemia inherited?
Familial Hyperalphalipoproteinemia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.